Dr. Mikhail Blagosklonny Deciphers the Healing Properties of Rapamycin Better
Dr. Mikhail Blagosklonny, a leading researcher who focuses on anti-aging and cancer, deciphered the incredible healing properties of Rapamycin. The drug that is also named as Sirolimus was used initially to avoid the organ transplant rejection. When it was isolated in 1972, it was first medicated as an anti-fungal agent. In the later years, scientists could identify many healing properties. But, Dr. Blagosklonny played a significant role in defining much of the properties of the drug, and he categorizes the drug for a number of uses that most people are not heard. He also proved that the medicine could provide excellent results in anti-aging treatments.Dr. Blagosklonny confirms that the drug can be used to prevent any principal reaction occurs on the human body when a new organ is transplanted into it. The physicians prescribe it as an anti-rejection medicine, in particular for kidneys due to its low toxicity level towards the organ. It is also a suitable option for the hemolytic-uremic syndrome. While people with the disease go for a kidney transplant, the new kidney develops the same illness, and Rapamycin can reduce such probabilities by reducing the toxicity in kidneys.
The drug is also an ideal solution for treating Lymphangioleiomyomatosis or LAM. It is a rare lung disease that affects women during their pregnancy stage, and Rapamycin is the approved primary medicine for the disease. Dr. Blagosklonny also says that it can be used for Coronary Stent Coating, to avoid the re-stenosis in the arteries after balloon angioplasty. Many studies have shown that people used this coating has remarkably fewer chances of a re-stenosis. It is also revealed that Rapamycin can effectively be used to treat Cancer due to its antiproliferative properties. It means that when the drug is taken in the right doses, it would improve the immune response and ensure increased resistance against cancer. It can also develop tumor regression. Dr. Blagosklonny also identified that the drug could effectively work on aging and Alzheimer’s disease. He conducted tests on mice and proved that it has the capacity to improve the anti-aging signals, and initial tests in human beings also produced similar results.
The studies are going on both anti-aging and Alzheimer’s disease.Apart from a researcher, Dr. Blagosklonny is a philanthropist and well-respected professor with more than a decade of experience in teaching and mentoring students. He aspires to create best treatment options for individuals that can produce most safe and efficient results while carrying a minimal cost. Dr. Blagosklonny thinks that by developing anti-aging drugs, he can change the quality of life of the humans, especially at the older ages. He is also an inspiration for the peer researchers with proven methodologies and result-driven works.Dr. Blagosklonny also wants to find a way that ensures effective treatment for cancer without causing any significant financial burden to the patients. He works on solutions that can remove cancer cells from the patients without damaging any of the healthy cells. It is considered to be very crucial when it comes to the recovery of the patients. Dr. Blagosklonny also collaborated with many medical and science journals by serving various roles on the editorial boards of the respective journals.